DEBT-FOR-EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • February 2nd, 2023 • Motorsport Games Inc. • Services-prepackaged software • Delaware
This DEBT-FOR-EQUITY EXCHANGE AGREEMENT (this “Agreement”), dated as of February 1, 2023 (the “Effective Date”) is made by and between Motorsport Games Inc., a Delaware corporation (the “Company”), and Motorsport Network, LLC, a Florida limited liability company (“MSN”).
EX-1.2 3 d381653dex12.htm FORM OF DEBT-FOR-EQUITY EXCHANGE AGREEMENT DEBT-FOR- EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • May 5th, 2020 • New York
DEBT-FOR-EQUITY EXCHANGE AGREEMENT dated as of [ ], 2013 (this “Agreement”), among PFIZER INC., a Delaware corporation (“Pfizer”), J.P. MORGAN SECURITIES LLC, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED and MORGAN STANLEY & CO. LLC (collectively, the “Investment Entities”), and, solely with respect to Sections 4(b) and 6 through 16 hereof, ZOETIS INC., a Delaware corporation and a direct, wholly owned subsidiary of Pfizer (“Zoetis”).
FORM OF DEBT-FOR-EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • September 23rd, 2013 • Marcus & Millichap, Inc. • Real estate agents & managers (for others) • Delaware
This DEBT-FOR-EQUITY EXCHANGE AGREEMENT dated as of [•], 2013 (this “Agreement”), is made among MARCUS & MILLICHAP COMPANY, a California corporation (“MMC”), GEORGE M. MARCUS, WILLIAM A. MILLICHAP, THE DONALD AND BEVERLY LORENZ LIVING TRUST, DONALD A. LORENZ 2012 DYNASTY TRUST, BEVERLY J. LORENZ 2012 DYNASTY TRUST, and LORENZ CAPITAL ASSETS, L.P., a California limited partnership (collectively, the “Debt Holders”), and, solely with respect to Sections 4(b) and 5 through 12 hereof, MARCUS & MILLICHAP, INC., a Delaware corporation (“MMI”).
DEBT-FOR-EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • October 8th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York
This DEBT-FOR-EQUITY EXCHANGE AGREEMENT (this “Agreement”), dated as of September 30, 2024 (the “Effective Date”) is made by and between Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada (the “Company”), and Newcourt SPAC Sponsor, LLC (“Lender”).
FORM OF] DEBT-FOR-EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • May 5th, 2020 • Minnesota
This DEBT-FOR-EQUITY EXCHANGE AGREEMENT (this “Agreement”), dated as of , 2017 (the “Effective Date”) is made by and between Sun BioPharma, Inc. a Delaware corporation (the “Company”), and the lender named on the signature page hereto (“Lender”).
DEBT FOR EQUITY EXCHANGE AGREEMENT This Debt For Equity Exchange Agreement, ("Agreement") is made the ____ day of February, 1997, between THERMACELL TECHNOLOGIES, INC. a Florida corporation ("Company") ___________ a resident of __________________...Debt for Equity Exchange Agreement • February 19th, 1997 • Thermacell Technologies Inc • Paints, varnishes, lacquers, enamels & allied prods
DEBT-FOR-EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • November 14th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Delaware
This DEBT-FOR-EQUITY EXCHANGE AGREEMENT (this “Agreement”), dated as of September 12, 2024 (the “Effective Date”), is made by and between Exicure, Inc., a Delaware corporation (the “Company”), and DGP Co., Ltd., a company organized under the laws of the Republic of Korea (“DGP”).
DEBT-FOR-EQUITY EXCHANGE AGREEMENTDebt-for-Equity Exchange Agreement • May 16th, 2023 • Atmus Filtration Technologies Inc. • Motor vehicle parts & accessories • New York
DEBT-FOR-EQUITY EXCHANGE AGREEMENT, dated as of [●], 2023 (this “Agreement”), among Cummins Inc., an Indiana corporation (“Cummins”), Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC (collectively, the “Investment Entities”). Capitalized terms used but not defined herein shall have the meanings set forth in the Underwriting Agreement (as defined below).
TO THE DEBT-FOR-EQUITY EXCHANGE AGREEMENT DATED AS OF SEPTEMBER 30, 2024 (the "Swap Agreement")Debt-for-Equity Exchange Agreement • December 4th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations
FIRST ADDENDUM (this "Addendum") TO THE DEBT-FOR-EQUITY EXCHANGE AGREEMENTS DATED AS OF SEPTEMBER 30, 2024 AND OCTOBER 25, 2024 RESPECTIVELY (collectively the "Swap Agreements")Debt-for-Equity Exchange Agreement • December 4th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations
